Morgan Stanley Uni Qure N.V. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Uni Qure N.V. stock. As of the latest transaction made, Morgan Stanley holds 1,518,228 shares of QURE stock, worth $6.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,518,228
Previous 1,759,818
13.73%
Holding current value
$6.77 Million
Previous $11.9 Million
33.74%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding QURE
# of Institutions
149Shares Held
34.1MCall Options Held
1.07MPut Options Held
603K-
Vestal Point Capital, LP New York, NY4.73MShares$21.1 Million2.03% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.09MShares$13.8 Million1.03% of portfolio
-
683 Capital Management, LLC New York, NY1.98MShares$8.81 Million0.88% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$8.3 Million0.0% of portfolio
-
Schroder Investment Management Group London, X01.24MShares$5.54 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $208M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...